VICTOR
ASENSI ALVAREZ
Catedrático de Universidad
![Foto de VICTOR](/img/nophoto.png)
![Foto de Hospital Carlos III](/img/noimage_org.png)
Hospital Carlos III
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Hospital Carlos III (21)
2017
2016
-
Impact of late presentation of HIV infection on short-, mid- and long-term mortality and causes of death in a multicenter national cohort: 2004-2013
Journal of Infection, Vol. 72, Núm. 5, pp. 587-596
-
MicroRNA profile in CD8+ T-lymphocytes from HIV-infected individuals: Relationship with antiviral immune response and disease progression
PLoS ONE, Vol. 11, Núm. 5
2015
-
Use of cohort data to estimate national prevalence of transmitted drug resistance to antiretroviral drugs in Spain (2007-2012)
Clinical Microbiology and Infection, Vol. 21, Núm. 1, pp. 105.e1-105.e5
2014
-
Abacavir/lamivudine plus darunavir/ritonavir in routine clinical practice: A multicentre experience in antiretroviral therapy-naive and -experienced patients
Journal of Antimicrobial Chemotherapy, Vol. 69, Núm. 9
-
Incidence of Hepatitis C Virus (HCV) in a multicenter cohort of HIV-positive patients in Spain 2004-2011: Increasing rates of HCV diagnosis but not of HCV seroconversions
PLoS ONE, Vol. 9, Núm. 12
-
Tuberculosis in a cohort of HIV-positive patients: Epidemiology, clinical practice and treatment outcomes
International Journal of Tuberculosis and Lung Disease, Vol. 18, Núm. 6
2013
-
Efficacy and tolerability of Darunavir/Ritonavir in combination with abacavir/lamivudine: An option in selected HIV-infected patients
HIV Clinical Trials, Vol. 14, Núm. 5, pp. 254-259
2012
-
Comparison of high ribavirin induction versus standard ribavirin dosing, plus peginterferon-for the treatment of chronic hepatitis C in HIV-infected patients: The PERICO trial
Journal of Infectious Diseases, Vol. 206, Núm. 6, pp. 961-968
-
Definition of advanced age in HIV infection: Looking for an age cut-off
AIDS Research and Human Retroviruses, Vol. 28, Núm. 9, pp. 800-806
2009
-
The Spanish HIV BioBank: A model of cooperative HIV research
Retrovirology, Vol. 6
2008
-
Incidence of anaemia and impact on sustained virological response in HIV/HCV-coinfected patients treated with pegylated interferon plus ribavirin
Journal of Viral Hepatitis, Vol. 15, Núm. 5, pp. 363-369
2007
-
Efficacy and safety of a once daily regimen with efavirenz, lamivudine, and didanosine, with and without food, as initial therapy for HIV infection: The ELADI study
AIDS Research and Human Retroviruses, Vol. 23, Núm. 10, pp. 1237-1241
-
Premature treatment discontinuation in HIV/HCV-coinfected patients receiving pegylated interferon plus weight-based ribavirin
Antiviral Therapy, Vol. 12, Núm. 4, pp. 469-476
-
Role of weight-based ribavirin dosing and extended duration of therapy in chronic hepatitis C in HIV-infected patients: The PRESCO trial
AIDS Research and Human Retroviruses, Vol. 23, Núm. 8, pp. 972-982
2006
-
Recommendations of the Study Group for Metabolic Alterations/Secretariat for the National AIDS Plan (GEAM/SPNS) on the management of metabolic and morphologic alterations in patients with HIV infection
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 24, Núm. 2, pp. 96-117
2005
-
GEAM/SPNS recommendations for managing metabolic and morphologic alterations in patients with HIV infection
Nutrition and Metabolic Disorders in HIV Infection, Vol. 4, Núm. 2, pp. 617-698
-
Simplification therapy with once-daily didanosine, tenofovir and efavirenz in HIV-1-infected adults with viral suppression receiving a more complex antiretroviral regimen: Final results of the EFADITE trial
Antiviral Therapy, Vol. 10, Núm. 7, pp. 825-832
2004
-
Consensus conference on chronic viral hepatitis and HIV infection: Updated Spanish recommendations
Journal of Viral Hepatitis
-
Hepatocellular carcinoma in HIV-infected patients: Epidemiological features, clinical presentation and outcome
AIDS, Vol. 18, Núm. 17, pp. 2285-2293